The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Letters to the editor

Letter: Pitfalls in aerobic capacity estimation of a chronic angina population

EuroIntervention 2021;16:1376-1377. DOI: 10.4244/EIJ-D-20-00676L

1. Department of Interventional Cardiology, Henry Dunant Hospital Center, Athens, Greece; 2. Interventional Cardiology Unit, GVM Care & Research Maria Cecilia Hospital, Cotignola, Italy


The study by Zivelonghi et al1 evaluated for the first time the effect of the coronary sinus reducer (CSR) in the exercise capacity of patients with chronic angina. Patients’ peak oxygen uptake (VO2peak) increased by 11%, six months after CSR implantation, suggesting a possible reduction of myocardial ischaemia. Indeed, we have recently demonstrated in a stress cardiac magnetic resonance (CMR)-based study that CSR decreased the ischaemic burden, providing a physiological rationale underlying its efficacy2. However, there are some concerns that should be taken into account to evaluate the results of this study.

Cardiopulmonary exercise test (CPET) ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Reply: Pitfalls in aerobic capacity estimation of a chronic angina population